Hungary vs United Arab Emirates: Previously treated cases tested for RR-/MDR-TB
Hungary
83.0%
in 2024
United Arab Emirates
83.0%
in 2024
Hungary rank
104th
United Arab Emirates rank
104th
Previously treated cases tested for RR-/MDR-TB over time
- Hungary
- United Arab Emirates
How they compare
Hungary currently reports 83.0% against 83.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 4 times across 14 shared years of data; in 2008 it was United Arab Emirates ahead.
Hungary ranks 104th and United Arab Emirates ranks 104th of 180 countries.
United Arab Emirates has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hungary | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.0% | 100.0% | 64.0% | United Arab Emirates |
| 2010s | 49.6% | 69.4% | 19.9% | United Arab Emirates |
| 2020s | 78.2% | 89.5% | 11.2% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Hungary or United Arab Emirates?
- Hungary, at 83.0% against 83.0% in United Arab Emirates as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Hungary and United Arab Emirates?
- 0.0%, with Hungary ahead.
- How many years of comparable data are there for Hungary and United Arab Emirates?
- 14 years are reported by both, from 2008 to 2024.
- How do Hungary and United Arab Emirates rank globally for previously treated cases tested for rr-/mdr-tb?
- Hungary ranks 104th and United Arab Emirates ranks 104th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.